BARCLAYS PLC - DIREXION SHS ETF TR ownership

DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 21 filers reported holding DIREXION SHS ETF TR in Q3 2023. The put-call ratio across all filers is 2.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of DIREXION SHS ETF TR
ValueSharesWeighting
Q3 2023$18
-10.0%
2000.0%0.00%
Q2 2023$20
+5.3%
2000.0%0.00%
Q1 2023$19
-17.4%
2000.0%0.00%
Q4 2022$23
-99.9%
2000.0%0.00%
Q3 2022$17,000
-19.0%
2000.0%0.00%
Q2 2022$21,000
+61.5%
200
+100.0%
0.00%
Q1 2022$13,000
-92.7%
100
-94.0%
0.00%
Q3 2021$179,000
+237.7%
1,663
+229.3%
0.00%
Q2 2021$53,0005050.00%
Other shareholders
DIREXION SHS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 55,597$2,523,0000.14%
Traynor Capital Management, Inc. 7,481$341,0000.12%
Virtu Financial LLC 49,149$2,230,0000.10%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 2,436$111,0000.08%
Capital Analysts, LLC 6,000$272,0000.03%
Acorn Wealth Advisors, LLC 395$18,0000.02%
BANQUE PICTET & CIE SA 10,120$459,0000.01%
Citadel Advisors 78,471$3,560,0000.00%
WOLVERINE TRADING, LLC 22,300$960,0000.00%
JANE STREET GROUP, LLC 21,346$968,0000.00%
View complete list of DIREXION SHS ETF TR shareholders